Skip to main content

Table 7 Comparisons of ROM between curcumin supplement and placebo

From: Effect of curcumin supplement or placebo in delayed onset muscle soreness: a systematic review and meta-analysis

Author

Curcumin

Placebo

N

Mean

SD

N

Mean

SD

(a) ROM preexercise

Tanabe Y

14

134

4

14

133

5

Tanabe Y

8

136.47

4.71

8

135.69

7.84

Tanabe Y (pre)

10

133.85

9.24

10

133.85

6.16

Tanabe Y (post)

10

136.92

6.93

10

133.85

6.93

UMD (95% CI)

   

1.18 (− 1.30, 3.67)

  

(b) ROM post-exercise

Tanabe Y

14

115.03

12.64

14

112.31

12.64

Tanabe Y

8

116.86

6.27

8

110.59

16.47

Tanabe Y (pre)

10

116.2

5.39

10

117.69

3.08

Tanabe Y (post)

10

119.28

110.77

10

110.04

12.32

UMD (95% CI)

   

 − 0.30 (− 3.71, 3.11)

  

(c) ROM at 24 h

Tanabe Y

14

116.76

12.07

14

113.46

9.196

Tanabe Y

8

112.98

10.98

8

113.73

11.76

Tanabe Y (pre)

10

109.23

5.39

10

112.31

9.23

Tanabe Y (post)

10

119.28

9.23

10

108.5

11.55

UMD (95%CI)

   

2.30 (− 3.78, 8.37)

  

(d) ROM at 48 h

Tanabe Y

14

118.48

12.64

14

114.03

8.62

Tanabe Y

8

106.67

12.55

8

105.88

14.11

Tanabe Y (pre)

10

103.11

6.16

10

107.69

12.31

Tanabe Y (post)

10

118.51

9.23

10

100.8

13.08

UMD (95%CI)

   

4.57 (− 4.85, 14.00)

4.57 (− 4.85, 14.00)

  

(e) ROM at 72 h

Tanabe Y

14

119.06

12.64

14

114.61

14.94

Tanabe Y

8

106.67

17.25

8

98.04

15.69

Tanabe Y (pre)

10

106.19

16.94

10

103.85

14.62

Tanabe Y (post)

10

120.05

10.77

10

96.95

15.38

UMD (95%CI)

   

9.84 (− 0.02, 19.70)

  

(f) ROM at 96 h

Tanabe Y

14

122.51

11.49

14

116.33

11.49

Tanabe Y

8

109.8

18.82

8

103.53

10.98

Tanabe Y (pre)

10

110.04

9.24

10

110.77

16.16

Tanabe Y (post)

10

123.85

9.23

10

103.88

10.77

UMD (95%CI)

   

8.45 (− 0.84, 17.74)